Racial and ethnic disparities in adherence to glaucoma follow-up visits in a county hospital population

Archives of Ophthalmology

Volumn 129, Issue 7, 2011, Pages 872-878

  Murakami, Yohko ^a   Lee, Bradford W ^a   Duncan, Martin ^a   Kao, Andrew ^b   Huang, Jehn Yu ^c   Singh, Kuldev ^a   Lin, Shan C ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA COLLECTION METHOD; DEMOGRAPHY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GLAUCOMA; HEALTH SERVICE; HEALTH SURVEY; HISPANIC; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHYSICIAN; POPULATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RACE DIFFERENCE; SYMPTOM; TREATMENT DURATION; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; CONTINUITY OF PATIENT CARE; ETHNIC GROUPS; FEMALE; GLAUCOMA; HEALTHCARE DISPARITIES; HOSPITALS, COUNTY; HUMANS; MALE; MIDDLE AGED; OFFICE VISITS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SAN FRANCISCO;

EID: 79960189229     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.163     Document Type: Article

References (28)

1. Giangiacomo AC. The epidemiology of glaucoma. In: Grehn F, Stamper R, eds. Glaucoma. Berlin, Germany: Springer; 2009:13-21.
2. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Opthalmol. 2002;120(6):701-730.
3. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121(1):48-56. (Pubitemid 36401765)
4. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z; EMGT Group. Predictors of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114(11):1965-1972. (Pubitemid 350016362)
5. Epstein DL, Krug JH Jr, Hertzmark E, Remis LL, Edelstein DJ. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology. 1989;96(10):1460-1467. (Pubitemid 19250953)
6. Kass MA. Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial. Trans Am Ophthalmol Soc. 1989;87:598-618. (Pubitemid 20128130)
7. Schulzer M, Drance SM, Douglas GR. A comparison of treated and untreated glaucoma suspects. Ophthalmology. 1991;98(3):301-307.
8. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200-209.
9. Friedman DS, Hahn SR, Quigley HA, et al. Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice. Ophthalmology. 2009;116(12):2277-2285.
10. American Academy of Ophthalmology Glaucoma Panel. Preferred Practice Patterns: Primary Open-Angle Glaucoma, Primary Open-Angle Glaucoma Suspect, and Primary Angel Closure. San Francisco, CA: American Academy of Ophthalmology; 2005.
11. Kosoko O, Quigley HA, Vitale S, Enger C, Kerrigan L, Tielsch JM. Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic. Ophthalmology. 1998;105(11):2105-2111. (Pubitemid 30211781)
12. Lee BW, Sathyan P, John RK, Singh K, Robin AL. Predictors of and barriers associated with poor follow-up in patients with glaucoma in South India. Arch Ophthalmol. 2008;126(10):1448-1454.
13. Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol. 2001;119(12):1819-1826. (Pubitemid 33139614)
14. Shimmyo M, Ross AJ, Moy A, Mostafavi R. Intraocular pressure, Goldmann applanation tension, corneal thickness, and corneal curvature in Caucasians, Asians, Hispanics, and African Americans. Am J Ophthalmol. 2003;136(4):603-613. (Pubitemid 37153174)
15. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma: the Baltimore Eye Survey. JAMA. 1991;266(3):369-374.
16. Kim E, Varma R. Glaucoma in Latinos/Hispanics. Curr Opin Ophthalmol. 2009;21(2):100-105.
17. Varma R, Ying-Lai M, Francis BA, et al; Los Angeles Latino Eye Study Group. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111(8):1439-1448. (Pubitemid 39030793)
18. Martin MJ, Sommer A, Gold EB, Diamond EL. Race and primary open-angle glaucoma. Am J Ophthalmol. 1985;99(4):383-387. (Pubitemid 15034497)
19. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. N Engl J Med. 1991;325(20):1412-1417.
20. Wormald RP, Basauri E, Wright LA, Evans JR. The African Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London. Eye (Lond). 1994;8(pt 3):315-320. (Pubitemid 24229718)
21. Gwira JA, Vistamehr S, Shelsta H, et al. Factors associated with failure to follow up after glaucoma screening: a study in an African American population. Ophthalmology. 2006;113(8):1315-1319.
22. Richardson JL, Langholz B, Bernstein L, Burciaga C, Danley K, Ross RK. Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer. 1992;65(6):922-926.
23. Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health. 2004;94(12):2104-2111. (Pubitemid 39578414)
24. Rauscher GH, Ferrans CE, Kaiser K, Campbell RT, Calhoun EE, Warnecke RB. Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2010;19(3):640-647.
25. Institute of Medicine. The healthcare environment and its relation to disparities. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: Institute of Medicine; 2003:29-80.
26. Institute of Medicine. Assessing potential sources of racial and ethnic disparities in care: patient- and system-level factors. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: Institute of Medicine; 2003:125-159.
27. Institute of Medicine. Assessing potential sources of racial and ethnic disparities in care in the clinical encounter. In: Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care.Washington, DC: Institute of Medicine; 2003:160-179.
28. US Department of Health&Human Services. National Healthcare Disparities Report. Washington, DC: US Dept of Health and Human Services; 2003.